Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A549
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drugs Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Country
5.5 Market Breakup by Therapy Area
5.6 Market Breakup by Drug Delivery
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Regulations in the Generic Industry
5.13 Key Market Drivers and Success Factors
6 Performance of Key Countries
6.1 United States
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 China
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Brazil
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Germany
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 France
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 India
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 United Kingdom
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Japan
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Canada
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Italy
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Others
6.11.1 Market Trends
6.11.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Key Player Profiles
10.3.1 Teva Pharmaceuticals Industries Ltd.
10.3.2 Mylan N.V.
10.3.3 Novartis AG
10.3.4 Pfizer Inc.
10.3.5 Sun Pharmaceutical Industries Ltd.
10.3.6 Fresenius SE & Co.
10.3.7 Lupin Limited
10.3.8 Endo Pharmaceuticals Inc.
10.3.9 Aurobindo Pharma Limited
10.3.10 Aspen Pharmacare Holdings Limited
11 Generic Drugs Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow (Tablets)
11.3 Detailed Process Flow (Injectable)
11.4 Various Types of Unit Operations Involved
11.5 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenditures
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenditures
12.7 Transportation Requirements and Expenditures
12.8 Utility Requirements and Expenditures
12.9 Manpower Requirements and Expenditures
12.10 Other Capital Investments
13 Loans and Financial Assistance
14 Project Economics
14.1 Capital Cost of the Project
14.2 Techno-Economic Parameters
14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
14.4 Taxation and Depreciation
14.5 Income Projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis
List of Figure
Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2023
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2023
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2023
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 13: China: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 17: Germany: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 19: France: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 21: India: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 25: Japan: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 27: Canada: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 29: Italy: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 31: Others: Generic Drugs Market (in Million US$), 2018 & 2023
Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2024-2032
Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2018 & 2023
Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2024-2032
Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2018 & 2023
Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2024-2032
Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2018 & 2023
Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2024-2032
Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2018 & 2023
Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2024-2032
Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2018 & 2023
Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2024-2032
Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2018 & 2023
Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2024-2032
Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2018 & 2023
Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2024-2032
Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2018 & 2023
Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2024-2032
Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2018 & 2023
Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2024-2032
Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2018 & 2023
Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2024-2032
Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2018 & 2023
Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2024-2032
Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2018 & 2023
Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2024-2032
Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2018 & 2023
Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2024-2032
Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2018 & 2023
Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2024-2032
Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2018 & 2023
Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2024-2032
Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 65: Generic Drugs Manufacturing: Detailed Process Flow
Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)
List of Table
Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2024-2032
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2024-2032
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2024-2032
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More